Production of Diagnostic Antibodies against exotoxin A of Pseudomonas aeruginosa., using Phage Display Technique

Technical Summary: Production of Diagnostic Antibodies against Pseudomonas aeruginosa Exotoxin A Using Phage Display

Problem Statement
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen responsible for severe nosocomial infections, particularly in immunocompromised patients, those with cystic fibrosis, burn victims, and individuals with chronic obstructive pulmonary disease (COPD). The bacterium's pathogenicity is largely driven by virulence factors, most notably Exotoxin A (ExoA), which inhibits protein synthesis in host cells via ADP-ribosylation of eukaryotic elongation factor 2. The rise of antibiotic resistance in P. aeruginosa necessitates alternative therapeutic and diagnostic strategies. While monoclonal antibodies offer a potential solution, traditional hybridoma methods face limitations regarding instability, the inability to generate fully human antibodies, and the requirement for animal immunization. This study addresses the need for a rapid, reliable method to produce specific antibodies against ExotoA for diagnostic and potential therapeutic applications.

Methodology
The research employed a phage display technique to generate single-chain variable fragment (scFv) antibodies specific to P. aeruginosa Exotoxin A. The workflow proceeded as follows:

1. Antigen Preparation: Exotoxin A was produced in Escherichia coli, then extracted, concentrated, and purified using ammonium sulfate precipitation, ion exchange chromatography, and gel filtration.
2. Immunization: BALB/c mice were immunized with crude Exotoxin A emulsified in Freund's adjuvants (complete for the initial injection, incomplete for subsequent boosts) to induce an immune response.
3. Library Construction:
   • RNA Isolation: Total RNA was extracted from the spleens of immunized mice.
   • cDNA Synthesis & PCR: Variable Heavy (VH) and Variable Light (VL) chain genes were amplified via RT-PCR. Gradient PCR optimized annealing temperatures (52.3°C for VH and 55.6°C for VL).
   • Assembly (SOE-PCR): The VH and VL fragments were linked using a (GGGGS)3 linker via Splicing by Overlap Extension (SOE) PCR to create 850 bp scFv constructs.
   • Cloning: The scFv inserts were digested with SfiI and ligated into the pADL-22C phagemid vector (digested with BglI) to create a phage display library.
   • Transformation: The recombinant phagemids were transformed into E. coli TG1 competent cells.
4. Biopanning: The scFv phage library underwent three rounds of biopanning against immobilized Exotoxin A to enrich for antigen-specific binders. Eluted phages were amplified and subjected to subsequent rounds.
5. Screening and Characterization:
   • Individual colonies from the enriched library were screened using sandwich ELISA against Exotoxin A (with BSA as a negative control).
   • Positive clones were verified via "touch clone" PCR to confirm the presence of the 850 bp scFv insert.
   • Plasmids from positive clones were purified, and the scFv sequences were determined via sequencing.
   • Sequence analysis was performed using VBASE2 and IgBlast databases to identify germline gene usage.

Key Results

• Library Generation: A functional scFv phage library was successfully constructed with a titer of $1.4 \times 10^8$ colony-forming units. Touch clone PCR confirmed a 100% recombination rate, with all tested clones containing the expected 850 bp scFv insert.
• Enrichment: Biopanning demonstrated a successful enrichment of specific binders. The output/input titration values increased significantly from the first to the third round.
• ELISA Screening: ELISA results showed a marked increase in binding affinity for panned phages compared to the original library and controls. The original library showed low absorbance (0.02–0.06 at 405 nm), similar to negative controls. The third round of panning yielded an average absorbance of 1.68, indicating high specificity for Exotoxin A.
• Clone Identification: Five clones (17, 28, 69, 81, and 95) exhibited the strongest signals. Sequencing of four random positive clones confirmed the presence of functional scFv sequences.
• Protein Characteristics: The study reported the production of bacterial proteins with a molecular weight of approximately 31.67 kDa, corresponding to the scFv fragments, demonstrating good selectivity and affinity.

Significance and Claims
The paper posits that phage display technology offers a superior alternative to traditional hybridoma methods for generating diagnostic antibodies. The study claims to have successfully identified and characterized mouse-derived scFv antibodies specific to P. aeruginosa Exotoxin A.

The authors emphasize the utility of this approach for:

• Rapid Antibody Production: Generating specific antibodies without the need for extensive animal testing or the instability issues associated with hybridoma cell lines.
• Diagnostic Potential: The identified scFvs can serve as tools for detecting Exotoxin A, a critical virulence factor, in clinical settings.
• Therapeutic Exploration: While the primary focus is diagnostic, the paper notes that neutralizing antibodies against virulent components could be used to treat infections, even those resistant to antibiotics.

The study concludes that the phage display technique is a versatile, repeatable, and cost-effective method for isolating antibodies against specific antigens, facilitating the development of new diagnostic tools and contributing to the broader understanding of protein-antigen interactions in the context of bacterial infections. The work highlights the potential of this technology to address challenges posed by antibiotic-resistant pathogens like P. aeruginosa.